Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Friedberg

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Translational Medicine|September 1, 2012
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsMichele Carbone, Laura Korb Ferris, Francine Baumann, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Journal of Translational Medicine|December 5, 2014
Evaluation of clonal origin of malignant mesotheliomaSabahattin Comertpay, Sandra Pastorino, Mika Tanji, et al.
Clinical Lung Cancer|October 20, 2018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at DiagnosisStephanie R Rice, Jason K Molitoris, Melissa A L Vyfhuis, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2018
Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" [Lung Cancer 114, (December 2017) 44-49]Melissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung CancerMelissa A L Vyfhuis, Whitney M Burrows, Neha Bhooshan, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Translational Medicine|September 1, 2012
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsMichele Carbone, Laura Korb Ferris, Francine Baumann, et al.
Advances in Radiation Oncology|November 9, 2017
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Whitney M Burrows, et al.
Journal of Translational Medicine|December 5, 2014
Evaluation of clonal origin of malignant mesotheliomaSabahattin Comertpay, Sandra Pastorino, Mika Tanji, et al.
Clinical Lung Cancer|October 20, 2018
Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non-small-cell Lung Cancer at DiagnosisStephanie R Rice, Jason K Molitoris, Melissa A L Vyfhuis, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
Lung Cancer (Amsterdam, Netherlands)|January 1, 2018
Corrigendum to "Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancer" [Lung Cancer 114, (December 2017) 44-49]Melissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
International Journal of Radiation Oncology, Biology, Physics|March 22, 2018
Implications of Pathologic Complete Response Beyond Mediastinal Nodal Clearance With High-Dose Neoadjuvant Chemoradiation Therapy in Locally Advanced, Non-Small Cell Lung CancerMelissa A L Vyfhuis, Whitney M Burrows, Neha Bhooshan, et al.
American Journal of Respiratory and Critical Care Medicine|June 7, 2011
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesotheliomaDaniel H Sterman, Andrew Haas, Edmund Moon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2016
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with ChemotherapyDaniel H Sterman, Evan Alley, James P Stevenson, et al.
Pageof 4